Literature DB >> 2009436

Use of hypnotherapy in gastrointestinal disease.

P J Whorwell1.   

Abstract

Recent controlled studies in the field of gastroenterology have shown that hypnotherapy is unequivocally beneficial in conditions such as irritable bowel syndrome and peptic ulceration. There is also some evidence for influence on certain physiological functions. Further research should help to define more clearly the role of this controversial form of therapy.

Entities:  

Mesh:

Year:  1991        PMID: 2009436

Source DB:  PubMed          Journal:  Br J Hosp Med        ISSN: 0007-1064


  9 in total

Review 1.  Non-pharmacological treatments in the irritable bowel syndrome.

Authors:  A Leahy; O Epstein
Journal:  World J Gastroenterol       Date:  2001-06       Impact factor: 5.742

2.  Chronic Functional Abdominal Pain (CFAP).

Authors: 
Journal:  Curr Treat Options Gastroenterol       Date:  2000-08

3.  Irritable bowel syndrome.

Authors:  E Beck; B Hurwitz
Journal:  Occas Pap R Coll Gen Pract       Date:  1992-12

Review 4.  Current views on the aetiology and management of the irritable bowel syndrome.

Authors:  M J Hall; R E Barry
Journal:  Postgrad Med J       Date:  1991-09       Impact factor: 2.401

Review 5.  Psychosocial aspects of the functional gastrointestinal disorders.

Authors:  D A Drossman; F H Creed; K W Olden; J Svedlund; B B Toner; W E Whitehead
Journal:  Gut       Date:  1999-09       Impact factor: 23.059

6.  Hypnotherapy for smoking cessation.

Authors:  Joanne Barnes; Hayden McRobbie; Christine Y Dong; Natalie Walker; Jamie Hartmann-Boyce
Journal:  Cochrane Database Syst Rev       Date:  2019-06-14

7.  Visceral sensation and emotion: a study using hypnosis.

Authors:  L A Houghton; E L Calvert; N A Jackson; P Cooper; P J Whorwell
Journal:  Gut       Date:  2002-11       Impact factor: 23.059

8.  Irritable Bowel Syndrome.

Authors:  Joel A. Sach; Lin Chang
Journal:  Curr Treat Options Gastroenterol       Date:  2002-08

Review 9.  Pathogenesis, Experimental Models and Contemporary Pharmacotherapy of Irritable Bowel Syndrome: Story About the Brain-Gut Axis.

Authors:  S W Tsang; K K W Auyeung; Z X Bian; J K S Ko
Journal:  Curr Neuropharmacol       Date:  2016       Impact factor: 7.363

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.